John Naftzger
Vermögen: 609 961 $ am 31.07.2026
Vermögen: 609 961 $ am 31.07.2026
John Christopher Naftzger currently works at Dyer Ellis & Joseph, as Associate.
Mr. Naftzger also formerly worked at Nabriva Therapeutics Plc, as CEO, Secretary & General Counsel in 2023, Chesapeake Corp., as Assistant Secretary & Assistant General Counsel in 2009, Koch Industries LLC, as Senior Counsel from 2006 to 2007, Unilife Corp., as Secretary, Chief Compliance Officer & VP from 2010 to 2014, Blank Rome LLP, as Partner, Unilife Medical Solutions, Inc., as Secretary, Chief Compliance Officer & VP, Nabriva Therapeutics Plc, as Vice President & Deputy General Counsel from 2017 to 2020, Krystal Biotech, Inc., as Secretary & Chief Legal Officer from 2020 to 2021, and Arbutus Biopharma Corp., as Secretary & Chief Compliance Officer from 2023 to 2025.
Mr. Naftzger received his undergraduate degree from Hampden-Sydney College, graduate degree from Willamette University, and graduate degree from Willamette University College of Law.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.02.2025 | 140 544 ( 0,07 % ) | 609 961 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Dyer Ellis & Joseph
Dyer Ellis & Joseph Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Compliance Officer | 28.03.2025 |
| NABRIVA THERAPEUTICS PLC | Vorstandsvorsitzender | 07.07.2023 |
| KRYSTAL BIOTECH, INC. | General Counsel | 01.05.2021 |
| NABRIVA THERAPEUTICS PLC | Corporate Officer/Principal | 01.01.2020 |
Chesapeake Corp.
Chesapeake Corp. Apparel/FootwearConsumer Non-Durables It engages in paper board and plastic packaging | Corporate Officer/Principal | 01.05.2009 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Chesapeake Corp.
Chesapeake Corp. Apparel/FootwearConsumer Non-Durables It engages in paper board and plastic packaging | Consumer Non-Durables |
Koch Industries LLC
Koch Industries LLC Oil Refining/MarketingEnergy Minerals Operates as a holding company whose subsidiaries involved in manufacturing, refining and distribution of petroleum, chemicals, fiber and polymers & paper products | Energy Minerals |
Arbutus Biopharma Corp.
Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Unilife Corp.
Unilife Corp. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets syringes & other medical devices | Health Technology |
Blank Rome LLP
Blank Rome LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Dyer Ellis & Joseph
Dyer Ellis & Joseph Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Hampden-Sydney College
Hampden-Sydney College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Willamette University
Willamette University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unilife Medical Solutions, Inc.
Unilife Medical Solutions, Inc. Medical SpecialtiesHealth Technology Manufactures medical and surgical devices | Health Technology |
Willamette University College of Law
Willamette University College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
Krystal Biotech, Inc.
Krystal Biotech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops gene therapies to patients living with debilitating diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen